Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 2 Comparative milestones in T and B lymphocyte maturation

Published byArnold Garey Day Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 2 Comparative milestones in T and B lymphocyte maturation"— Presentation transcript:

1 Figure 2 Comparative milestones in T and B lymphocyte maturation
Comparative milestones in T and B lymphocyte maturation (A) T cell development. (B) B cell development. Each lineage is represented with distinguishing markers for corresponding stages, and where cell commitment occurs. Arrows indicate potential points along the development pathway where immune tolerizing interventions might be targeted in neuromyelitis optica/spectrum disorder. CAR = chimeric antigen receptor; CD = class designation marker; CLP = common lymphoid precursor; DN = double-negative thymocyte; DP = double-positive CD4+/CD8+ thymocyte; Ig = immunoglobulin; ImmB = immature B cell; ISP = immature single-positive CD8+ thymocyte; LPreB = large PreB; MatB = mature B cell; PreB = pre-B cell receptor B cell; ProB = progenitor B cell; SP = single positive CD4+ or CD8+ thymocyte; SPreB = small PreB; TcR = T cell receptor; Treg = regulatory T cell. Larry Steinman et al. Neurol Neuroimmunol Neuroinflamm 2016;3:e276 © 2016 American Academy of Neurology

Download ppt "Figure 2 Comparative milestones in T and B lymphocyte maturation"

Similar presentations

T cell ontology Penny Morel 5/13/08. General issues Introduce “thymocyte” to replace immature Make definitions more precise. DN1 thymocyte - CD4 - CD8.

T cell ontology Penny Morel 5/13/08. General issues Introduce “thymocyte” to replace immature Make definitions more precise. DN1 thymocyte - CD4 - CD8.
DIFFERENTIATION AND MATURATION OF T CELLS IN THE THYMUS.

DIFFERENTIATION AND MATURATION OF T CELLS IN THE THYMUS.
DIFFERENTIATION AND MATURATION OF T CELLS IN THE THYMUS.

DIFFERENTIATION AND MATURATION OF T CELLS IN THE THYMUS.
T-cell development central tolerance. The cellular organization of the thymus.

T-cell development central tolerance. The cellular organization of the thymus.
DIFFERENTIATION AND MATURATION OF T CELLS IN THE THYMUS.

DIFFERENTIATION AND MATURATION OF T CELLS IN THE THYMUS.
Chapter 13 Lymphocyte Maturation and Antigen Receptor Expression

Chapter 13 Lymphocyte Maturation and Antigen Receptor Expression
Chapter 8 The Development and Survival of Lymphocytes.

Chapter 8 The Development and Survival of Lymphocytes.
T-cell development in the thymus

T-cell development in the thymus
Development of B and T lymphocytes

Development of B and T lymphocytes
Chapter 9 T-cell Development

Chapter 9 T-cell Development
Antibody-modified T cells: CARs take the front seat for hematologic malignancies by Marcela V. Maus, Stephan A. Grupp, David L. Porter, and Carl H. June.

Antibody-modified T cells: CARs take the front seat for hematologic malignancies by Marcela V. Maus, Stephan A. Grupp, David L. Porter, and Carl H. June.
T cell development.

T cell development.
Figure 3 Immunohistochemical analyses of positive and negative Epstein-Barr virus (EBV) control tissues using immunostaining Immunohistochemical analyses.

Figure 3 Immunohistochemical analyses of positive and negative Epstein-Barr virus (EBV) control tissues using immunostaining Immunohistochemical analyses.
Figure 4 Relation of neuropsychological deficits and intrathecal immune cell subsets in GABAB receptor antibody–associated limbic encephalitis Relation.

Figure 4 Relation of neuropsychological deficits and intrathecal immune cell subsets in GABAB receptor antibody–associated limbic encephalitis Relation.
Figure 1 Treg percentage and suppressive function increased during each round of Treg infusions Treg percentage and suppressive function increased during.

Figure 1 Treg percentage and suppressive function increased during each round of Treg infusions Treg percentage and suppressive function increased during.
Figure 3 Immune response to neoantigen: Geometric mean titers of antirabies antibody levels over timeAt days 31 and 38, all subjects achieved antibody.

Figure 3 Immune response to neoantigen: Geometric mean titers of antirabies antibody levels over timeAt days 31 and 38, all subjects achieved antibody.
Figure 2 Brain-infiltrating immune cells mainly consist of CD8+ memory T cells Immunofluorescence staining of brain-infiltrating immune cells. Brain-infiltrating.

Figure 2 Brain-infiltrating immune cells mainly consist of CD8+ memory T cells Immunofluorescence staining of brain-infiltrating immune cells. Brain-infiltrating.
Figure 1 Effect of DMF therapy on T cell subsets

Figure 1 Effect of DMF therapy on T cell subsets
Figure 1 Integrative model of NMO/SD pathogenesis

Figure 1 Integrative model of NMO/SD pathogenesis
Figure 2 Brain biopsy Brain biopsy (A) Double staining with anti-aquaporin-4 (AQP4) antibody (dark green) and Luxol fast blue (blue) is shown. Loss of.

Figure 2 Brain biopsy Brain biopsy (A) Double staining with anti-aquaporin-4 (AQP4) antibody (dark green) and Luxol fast blue (blue) is shown. Loss of.

Similar presentations

Ads by Google